RSLS – reshape lifesciences, inc. (US:NASDAQ)
Stock Stats
News
4/1
04:08 pm
rsls
Medium
ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update [Yahoo! Finance]
4/1
04:05 pm
rsls
Medium
ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update
3/28
08:40 am
rsls
Medium
ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System [Yahoo! Finance]
3/28
08:31 am
rsls
Medium
ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System
3/4
09:06 am
rsls
Medium
ReShape Lifesciences sees 55.4% fall in Y/Y expenses in 2024 with cost cut plan [Seeking Alpha]
4/10
04:57 pm
rsls
Low
Form 8-K ReShape Lifesciences For: Apr 09
4/10
06:02 am
rsls
Medium
Form 8-K ReShape Lifesciences For: Apr 08
4/4
11:12 am
rsls
Medium
Form 8-K ReShape Lifesciences For: Apr 01
4/1
05:19 pm
rsls
Medium
Form 10-K ReShape Lifesciences For: Dec 31
2/26
04:21 pm
rsls
Medium
Form 8-K ReShape Lifesciences For: Feb 23
Show more
Top News Gainers
11/11 ReShape Lifesciences Announces 1-for-120 Reverse Stock Split 56.4%
9/4 Form 4 ReShape Lifesciences For: Aug 30 Filed by: Armistice Capital Master Fund Ltd. 16.7%
6/4 ReShape Lifesciences Strengthens Executive Leadership Team with Appointment of Kevin Condrin as Senior Vice President of Commercial 13.6%
5/20 ReShape Lifesciences to Host First Quarter 2019 Conference Call on May 20, 2019 12.5%
4/17 Form 8-K ReShape Lifesciences For: Apr 12 8.7%
2/4 Form 8-K ReShape Lifesciences For: Feb 01 8.2%
8/15 Form NT 10-Q ReShape Lifesciences For: Jun 30 8.0%
9/30 Form 8-K ReShape Lifesciences For: Sep 23 7.1%
10/30 Form 8-K ReShape Lifesciences For: Oct 30 5.3%
9/30 Form SC 13D/A ReShape Lifesciences Filed by: ARMISTICE CAPITAL, LLC 5.0%
Top News Decliners
12/28 Form 8-K ReShape Lifesciences For: Dec 27 -27.5%
3/29 ReShape Lifesciences Announces $2 Million Convertible Note Financing -27.4%
11/26 ReShape Lifesciences Announces $10 Million Registered Direct Offering -24.8%
11/14 Form 8-K ReShape Lifesciences For: Nov 14 -24.7%
5/16 Form 10-K ReShape Lifesciences For: Dec 31 -17.9%
5/20 Q1/2019 3/31/2019 EPS -0.540 ZacksConsensus N/A ActVsEst N/A - N/A -16.7%
10/18 Form DEF 14A ReShape Lifesciences For: Oct 31 -12.3%
8/9 Form 4 ReShape Lifesciences For: Aug 07 Filed by: Armistice Capital Master Fund Ltd. -11.4%
10/1 Form SC 13G/A ReShape Lifesciences Filed by: BIGGER CAPITAL FUND L P -11.1%
6/20 Form SC 13G ReShape Lifesciences Filed by: BIGGER CAPITAL FUND L P -9.8%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3